((2R,3R,4R,5R)-3-Acetoxy-5-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-2-yl)methyl acetate
95%
- Product Code: 123575
CAS:
1188522-91-9
| Molecular Weight: | 409.16 g./mol | Molecular Formula: | C₁₃H₁₄BrFN₂O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22124295 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, sealed, dry |
Product Description:
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research as a key intermediate in the synthesis of nucleoside analogs. These analogs are crucial in the development of antiviral and anticancer drugs, particularly those targeting viral replication and cellular proliferation. Its structure, featuring bromo and fluoro substituents, enhances its ability to mimic natural nucleosides, allowing it to integrate into DNA or RNA chains and disrupt the function of viral or cancer cells. Researchers also explore its potential in modifying nucleic acids for therapeutic applications, including gene therapy and the design of oligonucleotides with enhanced stability and specificity.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £75.31 |
+
-
|
| 0.250 | 10-20 days | £128.03 |
+
-
|
| 1.000 | 10-20 days | £332.40 |
+
-
|
((2R,3R,4R,5R)-3-Acetoxy-5-(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-2-yl)methyl acetate
This chemical is primarily utilized in the field of medicinal chemistry and pharmaceutical research as a key intermediate in the synthesis of nucleoside analogs. These analogs are crucial in the development of antiviral and anticancer drugs, particularly those targeting viral replication and cellular proliferation. Its structure, featuring bromo and fluoro substituents, enhances its ability to mimic natural nucleosides, allowing it to integrate into DNA or RNA chains and disrupt the function of viral or cancer cells. Researchers also explore its potential in modifying nucleic acids for therapeutic applications, including gene therapy and the design of oligonucleotides with enhanced stability and specificity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :